var data={"title":"Mupirocin: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Mupirocin: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6610?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=mupirocin-drug-information\" class=\"drug drug_general\">see &quot;Mupirocin: Drug information&quot;</a> and <a href=\"topic.htm?path=mupirocin-patient-drug-information\" class=\"drug drug_patient\">see &quot;Mupirocin: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198518\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Bactroban;</li>\n      <li>Bactroban Nasal;</li>\n      <li>Centany;</li>\n      <li>Centany AT</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198519\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Bactroban</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048737\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antibiotic, Topical</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F12675222\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>MRSA decolonization:</b> Limited data available; dosing regimens variable (Nelson 2014): Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Nasal site: Intranasal ointment: Apply a small amount to both anterior nares 2 to 3 times/day for 5 to 10 days in conjunction with umbilical application of topical ointment (Bertin 2006; Huang 2015; IDSA [Liu 2011]; Wisgrill 2017)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Umbilical site: Ointment: Apply a small amount to umbilicus 2 to 3 times/day for 5 to 10 days in conjunction with intranasal application (Bertin 2006; Huang 2015; Lally 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>MRSA or impetigo, treatment; minor skin infection or limited number of infected lesions:</b> Limited data available: Ointment: Topical: Apply a small amount 3 times daily for 5 to 10 days (Bradley 2017; IDSA [Liu 2011])</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048733\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=mupirocin-drug-information\" class=\"drug drug_general\">see &quot;Mupirocin: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>MRSA decolonization, nasal:</b> Topical: Intranasal ointment:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants and Children: Limited data available: Apply a small amount twice daily for 5 to 10 days (IDSA [Liu 2011])</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;12 years and Adolescents: Apply 500 mg (<sup>1</sup>/<sub>2</sub> of unit-dose tube) twice daily for 5 to 10 days (IDSA [Liu 2011])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>MRSA or impetigo, treatment; minor skin infection or a limited number of infected lesions:</b> Infants, Children, and Adolescents: Topical: Cream, Ointment: Apply small amount 3 times daily for 5 to 10 days; patients not showing clinical response after 5 days should be reevaluated (IDSA [Liu 2011]; IDSA [Stevens 2014])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Elimination of MRSA colonization:</b> Intranasal: Approximately one-half of the ointment from the single-use tube should be applied into one nostril and the other half into the other nostril twice daily (morning and evening) for 5 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Impetigo: </b>Topical: Ointment: Apply to affected area 3 times daily; reevaluate after 3 to 5 days if no clinical response</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Secondary skin infections:</b> Topical: Cream: Apply to affected area 3 times daily for 10 days; reevaluate after 3 to 5 days if no clinical response</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment: </b>There are no dosage adjustments provided in the manufacturer's labeling (has not been studied).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment: </b>There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198500\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as calcium [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Bactroban: 2% (15 g, 30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (15 g, 30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Centany AT: 2% [contains propylene glycol monostearate]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Bactroban: 2% (22 g [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Centany: 2% (30 g) [contains propylene glycol monostearate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (15 g, 22 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment, Nasal, as calcium [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Bactroban Nasal: 2% (1 g)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198487\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048740\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Topical: Wash hands before application.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Intranasal ointment: Apply to anterior nares; press sides of the nose together and gently massage for 1 minute after application to spread ointment throughout the inside of the nostrils. Packaged in single-use tubes; discard after use; do not reuse. Not for use in eyes. In case of accidental contact in or near eyes, rinse well with water. Do not apply concurrently with any other intranasal products. Wash hands after application.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical cream, ointment: For external use only; not formulated for use on mucosal surfaces; do not apply into the eye or use intranasally (components may be absorbed systemically and cause drying and irritation). Apply a small amount to affected area using cotton swab or gauze pad; may cover area with gauze dressing if desired. In case of accidental contact in or near eyes, rinse well with water. Do not use concurrently with any other lotions, creams, or ointments.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24773676\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Intranasal: Store between 20&deg;C and 25&deg;C (68&deg;F and 77&deg;F); excursions are permitted between 15&deg;C and 30&deg;C (59&deg;F and 86&deg;F). Do not refrigerate. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical cream: Store at or below 25&deg;C (77&deg;F). Do not freeze.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical ointment: Store between 20&deg;C and 25&deg;C (68&deg;F and 77&deg;F).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048739\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Intranasal ointment: Eradication of <i>Staphylococcus aureus</i> from nasal carriage sites as part of an infection control program to reduce the risk of infection among patients at high risk of MRSA infection during institutional outbreaks (FDA approved in ages &ge;12 years and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical cream: Topical treatment of secondarily-infected traumatic skin lesions due to susceptible strains of <i>S. aureus</i> and <i>Streptococcus pyogenes</i> (FDA approved in ages &ge;3 months and adults); has also been used for prophylaxis at intravenous catheter exit sites</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical ointment: Topical treatment of impetigo caused by susceptible strains of  <i>S. aureus</i> and <i>S. pyogenes</i> (FDA approved in ages &ge;2 months and adults)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198564\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Bactroban may be confused with bacitracin, baclofen, Bactrim</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198562\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Central nervous system: Headache, localized burning, stinging sensation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dermatologic: Pruritus, skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gastrointestinal: Dysgeusia, nausea</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Local: Local pain</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Respiratory: Cough, respiratory congestion, rhinitis, pharyngitis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Rare but important or life-threatening: Aphthous stomatitis, blepharitis, cellulitis, <i>Clostridium difficile</i> associated diarrhea, dermatitis, epistaxis, hypersensitivity reaction, increased wound secretion, xeroderma</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198504\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to mupirocin or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198491\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity: May be associated with systemic allergic reactions, including anaphylaxis, urticarial, angioedema, and generalized rash. If a systemic reaction occurs, discontinue use.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Irritation: If sensitization or local irritation occurs, discontinue use.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including <i>C. difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Renal impairment: Topical ointment and intranasal: Use with caution in patients with renal impairment (has not been studied).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&quot;gasping syndrome&quot;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Polyethylene glycol: Potentially toxic amounts of polyethylene glycol contained in some topical products may be absorbed percutaneously in patients with extensive burns or open wounds. Do not use polyethylene glycol-based ointments in conditions where absorption of large quantities of polyethylene glycol is possible, especially in the presence of moderate or severe renal impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: For external use only. Avoid contact with eyes; in case of accidental contact in or near eyes, rinse well with water.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">- Intranasal: May cause severe burning and tearing in eyes (resolves within days to weeks after discontinuation). Available in single-use tubes to decrease risk of contamination.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">- Topical cream and ointment: Not for ophthalmic or nasal use or use on mucosal surfaces. May cover treated areas with gauze dressing.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Limitations of use:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">- Nasal ointment: There are insufficient data to establish that product is safe and effective as part of an intervention program to prevent autoinfection of high-risk patients from their own nasal colonization with <i>S. aureus</i>; should not be used for general prophylaxis of any infection in any patient population; &gt;90% of patients had eradication of nasal colonization within 2 to 4 days after therapy was completed; ~30% recolonization within 4 weeks of therapy was reported in one study.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">- Topical ointment: Should not be used with intravenous (IV) cannulae or at central IV sites because of the potential to promote fungal infections and antimicrobial resistance.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26535365\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299730\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198495\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12622&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198508\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Systemic absorption following topical application is minimal.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198490\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Binds to bacterial isoleucyl transfer-RNA synthetase resulting in the inhibition of protein synthesis</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198503\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Topical ointment and cream: Penetrates outer layers of skin; systemic absorption minimal through intact skin</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Intranasal: Adults: ~3%; Neonates and premature infants: Absorption may be significant</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Protein binding: &gt;97%</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Rapidly metabolized to monic acid (inactive)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life: 17 to 36 minutes</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (as monic acid [inactive])</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198507\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Bactroban External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (15 g): $124.93</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Mupirocin Calcium External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (15 g): $245.16</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Centany AT External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (1): $306.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Bactroban Nasal Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (1 g): $20.49</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Centany External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (30 g): $306.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Mupirocin External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (22 g): $38.70</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F198509\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Bacidal (TH);</li>\n      <li>Bacron (BD);</li>\n      <li>Bactafect (TH);</li>\n      <li>Bactermin (TW);</li>\n      <li>Bactex (TH);</li>\n      <li>Bactifree (PH);</li>\n      <li>Bactocin (BR, PH);</li>\n      <li>Bactoderm (ID, IL);</li>\n      <li>Bactokil (TH);</li>\n      <li>Bactokill (BD);</li>\n      <li>Bactreat (PH);</li>\n      <li>Bactrobaan (DE);</li>\n      <li>Bactroban (AE, AR, AT, AU, BB, BD, BE, BF, BG, BH, BJ, BM, BR, BS, BZ, CH, CI, CL, CN, CY, CZ, DK, EG, ES, ET, FI, FR, GB, GH, GM, GN, GR, GY, HK, HU, ID, IE, IL, IN, IQ, IR, IS, IT, JM, JO, JP, KE, KR, KW, LB, LR, LU, LY, MA, ML, MR, MU, MW, MX, MY, NE, NG, NL, NO, NZ, OM, PH, PK, PL, PR, PT, PY, QA, RU, SA, SC, SD, SE, SG, SI, SK, SL, SN, SR, SY, TH, TN, TR, TT, TW, TZ, UA, UG, UY, VE, VN, YE, ZA, ZM, ZW);</li>\n      <li>Bactroban Nasal Ointment (AU);</li>\n      <li>Bactrocin (LK);</li>\n      <li>Banbact (TH);</li>\n      <li>Bantix (CN, PY);</li>\n      <li>Betrion (HR);</li>\n      <li>Dermasafe (TW);</li>\n      <li>Dermatech Bantix (CO);</li>\n      <li>Dermucor S (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Esroban (KR);</li>\n      <li>Foskina (PH);</li>\n      <li>Mertus (ID);</li>\n      <li>Mupiban (LK);</li>\n      <li>Mupicin (PH);</li>\n      <li>Mupider (NZ, SG);</li>\n      <li>Mupiderm (FR);</li>\n      <li>Mupiral (EC);</li>\n      <li>Mupiroban (KR);</li>\n      <li>MupiroNasal (BG);</li>\n      <li>Mupirox (AR, PE);</li>\n      <li>Mupirox Nasal (AR);</li>\n      <li>Muporin (TH);</li>\n      <li>Muprin (HK, ID, LK, MY, PH);</li>\n      <li>Muropa (HK);</li>\n      <li>Murozin (MY);</li>\n      <li>Pibaksin (ID, LK);</li>\n      <li>Plasimmine (ES);</li>\n      <li>Sinpebac (MX);</li>\n      <li>Spectroderm (PE);</li>\n      <li>Supirocin (MY, SG, TH, ZW);</li>\n      <li>Systop (BD);</li>\n      <li>Tapocin (BD);</li>\n      <li>Turixin (DE);</li>\n      <li>Vidox (UY)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/11487763 /pubmed\" target=\"_blank\" id=\"11487763 \">11487763 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bactroban (mupirocin) cream [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; March 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bactroban (mupirocin) ointment [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; March 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bactroban Nasal (mupirocin) ointment [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; March 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bertin ML, Vinski J, Schmitt S, et al, &quot;Outbreak of Methicillin-Resistant <i>Staphylococcus aureus</i> Colonization and Infection in a Neonatal Intensive Care Unit Epidemiologically Linked to a Healthcare Worker With Chronic Otitis,&quot; <i>Infect Control Hosp Epidemiol</i>, 2006, 27(6):581-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/16755477/pubmed\" target=\"_blank\" id=\"16755477\">16755477</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bradley JS, Nelson JD, Barnett E, et al. <i>Nelson's Pediatric Antimicrobial Therapy</i>. 23rd ed. American Academy of Pediatrics; 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Britton JW, Fajardo JE, and Krafte-Jacobs B, &ldquo;Comparison of Mupirocin and Erythromycin in the Treatment of Impetigo,&rdquo; <i>J Pediatr</i>, 1990, 117(5):827-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/2121951/pubmed\" target=\"_blank\" id=\"2121951\">2121951</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol - United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. Available at <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/6810084 /pubmed\" target=\"_blank\" id=\"6810084 \">6810084 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hayakawa T, Hayashidera T, Katsura S, et al, &ldquo;Nasal Mupirocin Treatment of Pharynx-Colonized Methicillin Resistant <i>Staphylococcus aureus</i>: Preliminary Study With 10 Carrier Infants,&rdquo; <i>Pediatr Int</i>, 2000, 42(1):67-70.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/10703239/pubmed\" target=\"_blank\" id=\"10703239\">10703239</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hitomi S, Kubota M, Mori N, et al, &ldquo;Control of a Methicillin-Resistant <i>Staphylococcus aureus</i> Outbreak in a Neonatal Intensive Care Unit by Unselective Use of Nasal Mupirocin Ointment,&rdquo; <i>J Hosp Infect</i>, 2000, 46(2):123-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/11049705 /pubmed\" target=\"_blank\" id=\"11049705 \">11049705 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Huang YC, Lien RI, Lin TY. Effect of mupirocin decolonization on subsequent methicillin-resistant <i>Staphylococcus aureus</i> infection in infants in neonatal intensive care units. <i>Pediatr Infect Dis J</i>. 2015;34(3):241-245.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/25742074/pubmed\" target=\"_blank\" id=\"25742074\">25742074</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lally RT, Lanz E, and Schrock CG, &quot;Rapid Control of an Outbreak of <i>Staphylococcus aureus</i> on a Neonatal Intensive Care Department Using Standard Infection Control Practices and Nasal Mupirocin,&quot; <i>Am J Infect Control</i>, 2004, 32(1):44-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/14755235/pubmed\" target=\"_blank\" id=\"14755235\">14755235</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Liu C, Bayer A, Cosgrove SE, et al, &quot;Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Infections in Adults and Children: Executive Summary,&quot; <i>Clin Infect Dis</i>, 2011, 52(3):285-92.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/21217178/pubmed\" target=\"_blank\" id=\"21217178\">21217178</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Nelson MU, Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. One size does not fit all: why universal decolonization strategies to prevent methicillin-resistant <i>Staphylococcus aureus</i> colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units. <i>J Perinatol</i>. 2014;34(9):653-655.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/25010223/pubmed\" target=\"_blank\" id=\"25010223\">25010223</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Oh J, von Baum H, Klaus G, et al, &ldquo;Nasal Carriage of <i>Staphylococcus aureus</i> in Families of Children on Peritoneal Dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS),&rdquo; <i>Adv Perit Dial</i>, 2000, 16:324-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/11045321 /pubmed\" target=\"_blank\" id=\"11045321 \">11045321 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Siegel JD, Rhinehart E, Jackson M, et al, &quot;2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings,&quot; <i>Am J Infect Control</i>, 2007, 35(10 Suppl 2):65-164. Available at <a href=\"http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf\" target=\"_blank\">http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/18068815/pubmed\" target=\"_blank\" id=\"18068815\">18068815</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Siegel JD, Rhinehart E, Jackson M, et al, &quot;Management of Multidrug-Resistant Organisms in Health Care Settings, 2006,&quot; <i>Am J Infect Control</i>, 2007, 35(10 Suppl 2):165-93.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/18068814/pubmed\" target=\"_blank\" id=\"18068814\">18068814</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2014;59(2):147-159.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/24947530/pubmed\" target=\"_blank\" id=\"24947530\">24947530</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wisgrill L, Zizka J, Unterasinger L, et al. Active surveillance cultures and targeted decolonization are associated with reduced methicillin-susceptible <i>Staphylococcus aureus</i> infections in VLBW infants. <i>Neonatology</i>. 2017;112(3):267-273.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mupirocin-pediatric-drug-information/abstract-text/28704818/pubmed\" target=\"_blank\" id=\"28704818\">28704818</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12622 Version 126.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F198518\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F198519\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1048737\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F12675222\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1048733\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F198500\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F198487\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1048740\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F24773676\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1048739\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F198564\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F198562\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F198504\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F198491\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26535365\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299730\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F198495\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F198508\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F198490\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F198503\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F198507\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F198509\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12622|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=mupirocin-drug-information\" class=\"drug drug_general\">Mupirocin: Drug information</a></li><li><a href=\"topic.htm?path=mupirocin-patient-drug-information\" class=\"drug drug_patient\">Mupirocin: Patient drug information</a></li></ul></div></div>","javascript":null}